Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGM0504 in Overweight or Obese Subjects Without Diabetes
NCT06973681Phase 2Completed
- Sponsor
- BrightGene Bio-Medical Technology
- Start
- Oct 2023
- Primary completion
- Sep 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BGM0504 in obesity, sponsored by BrightGene Bio-Medical Technology. Started Oct 2023; status: completed.
02
Drugs
BGM0504
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06973681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06973681.